Lipid-lowering therapy after coronary artery bypass surgery: The Post-CABG trial

William J. Stewart, MD
Dr. Stewart is a cardiologist at the Cleveland Clinic and a site co-principal investigator in the Post-CABG trial.

Byron J. Hoogwerf, MD
Dr. Hoogwerf is a staff endocrinologist at the Cleveland Clinic and the site principal investigator in the Post-CABG trial. For a complete listing of trial investigators see reference 1.

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; hoogweb@cesmtp.ccf.org

William J. Stewart, MD
Dr. Stewart is a cardiologist at the Cleveland Clinic and a site co-principal investigator in the Post-CABG trial.

Byron J. Hoogwerf, MD
Dr. Hoogwerf is a staff endocrinologist at the Cleveland Clinic and the site principal investigator in the Post-CABG trial. For a complete listing of trial investigators see reference 1.

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; hoogweb@cesmtp.ccf.org

William J. Stewart, MD
Dr. Stewart is a cardiologist at the Cleveland Clinic and a site co-principal investigator in the Post-CABG trial.

Byron J. Hoogwerf, MD
Dr. Hoogwerf is a staff endocrinologist at the Cleveland Clinic and the site principal investigator in the Post-CABG trial. For a complete listing of trial investigators see reference 1.

Address: Byron J. Hoogwerf, MD, Department of Endocrinology, A30, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; hoogweb@cesmtp.ccf.org